5AM Venture Management, LLC Long-Term Concentrated

CIK: 0001799883 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 5, 2020

Total Value ($000): $456,625 (100.0% shares, 0.0% debt)

Holdings (9)

— Akouos Inc. 22.7%

Value ($000) $103,630 Shares 4,605,784 Est. Cost $22.50 Unrealized —

— Aprea Therapeutics, Inc. 18.8%

Value ($000) $85,807 Shares 2,212,654 Est. Cost $45.89 Unrealized —

— Homology Medicines, Inc. 18.4%

Value ($000) $84,091 Shares 5,535,919 Est. Cost $20.70 Unrealized —

IDYA IDEAYA Biosciences, Inc. 10.8%

Value ($000) $49,210 Shares 3,463,066 Est. Cost $7.13 Unrealized +10.4%

CABA Cabaletta Bio, Inc. 9.0%

Value ($000) $40,876 Shares 3,669,263 Est. Cost $11.85 Unrealized -35.4%

ARVN Arvinas, Inc. 7.3%

Value ($000) $33,540 Shares 1,000,000 Est. Cost $29.28 Unrealized +45.0%

— scPharmaceuticals Inc. 6.2%

Value ($000) $28,200 Shares 3,831,474 Est. Cost $5.92 Unrealized —

CRNX Crinetics Pharmaceuticals, Inc. 5.2%

Value ($000) $23,867 Shares 1,362,286 Est. Cost $19.04 Unrealized -10.5%

— Cidara Therapeutics, Inc. 1.6%

Value ($000) $7,404 Shares 2,006,511 Est. Cost $3.84 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Akouos Inc.	4,605,784	$103,630	22.7%	$22.50	—	COM	00973J101
—	Aprea Therapeutics, Inc.	2,212,654	$85,807	18.8%	$45.89	—	COM	03836J102
—	Homology Medicines, Inc.	5,535,919	$84,091	18.4%	$20.70	—	COM	438083107
IDYA	IDEAYA Biosciences, Inc.	3,463,066	$49,210	10.8%	$7.13	+10.4%	COM	45166A102
CABA	Cabaletta Bio, Inc.	3,669,263	$40,876	9.0%	$11.85	-35.4%	COM	12674W109
ARVN	Arvinas, Inc.	1,000,000	$33,540	7.3%	$29.28	+45.0%	COM	04335A105
—	scPharmaceuticals Inc.	3,831,474	$28,200	6.2%	$5.92	—	COM	810648105
CRNX	Crinetics Pharmaceuticals, Inc.	1,362,286	$23,867	5.2%	$19.04	-10.5%	COM	22663K107
—	Cidara Therapeutics, Inc.	2,006,511	$7,404	1.6%	$3.84	—	COM	171757107